Monday, July 08, 2013

Prophylactic platelet transfusion in patients with hematologic malignancy

Recently published in NEJM:

The results of our study support the need for the continued use of prophylaxis with platelet transfusion and show the benefit of such prophylaxis for reducing bleeding, as compared with no prophylaxis. A significant number of patients had bleeding despite prophylaxis.

No comments: